St. Jude Children’s Research Hospital investigators said the results reinforce the importance of hand washing and other measures to help protect vulnerable patients from influenza infections.
Investigators at Case Western Reserve University School of Medicine and University Hospitals Health System have identified a new molecular pathway that controls lifespan and healthspan in worms and mammals. In a Nature Communications study published today, researchers showed that worms with excess levels of certain proteins lived longer and healthier than normal worms. In addition, mice with excess levels of these proteins demonstrated a delay in blood vessel dysfunction associated with aging. The study has major implications for our understanding of aging and age-associated disorders.
Nearly 40 members of Congress received training today from surgeon members of the American College of Surgeons (ACS) in how to stop potentially life-threatening bleeding.
Leaders in HIV research and treatment gather at UAB to address laws that prohibit gay men from donating blood.
Two new papers from researchers at Fred Hutchinson Cancer Research Center provide the most comprehensive data yet reported on side effects of the emerging cancer immunotherapy strategy known as CAR T-cell therapy.
Despite prevention efforts, researchers have found a significant increase over a 10-year period in the percentage of people with stroke who have high blood pressure, diabetes, smoking and other risk factors for stroke. The study is published in the October 11, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Goal of new Intermountain Healthcare genomics study is to show whether screening patients for the presence of circulating tumor DNA, known as ctDNA, can successfully detect breast cancer using a blood draw.
The world's "better" countries, with greater access to healthcare, experience much higher rates of cancer incidence than the world's "worse off" countries, according to new research from the University of Adelaide.
Cells lining blood vessels in the lungs that are exposed to bacterial toxins don’t die easy, according to a new study led by researchers at the University of Illinois at Chicago College of Medicine.
Scientists at Albert Einstein College of Medicine have discovered the first compound that directly makes cancer cells commit suicide while sparing healthy cells. The new treatment approach, described in today’s issue of Cancer Cell, was directed against acute myeloid leukemia (AML) cells but may also have potential for attacking other types of cancers.
An international research effort led by Duke Cancer Institute scientists has been working to better understand the genetic underpinnings of the most prevalent form of this cancer -- diffuse large B cell lymphoma – and how those genes might play a role in patients’ responses to therapies.
Researchers from the University of Toledo (Ohio) College of Medicine and Life Sciences have discovered more than 12,000 different types of noncoding RNA (circRNAs) in the kidney tissue of rats. This type of genetic material, previously thought to have no function, may play a significant role in regulating blood pressure in heart and kidney disease.
No disorder appears to kill more people than atherosclerosis, and hopeful experimental treatments with "good cholesterols" have failed. New research reapproaches them with carefully designed cholesterols in an organ-on-a-chip in highly reproducible experiments.
Researchers have shown, for the first time, that reduced dietary potassium promotes elevated aortic stiffness in a mouse model. Such arterial stiffness in humans is predictive of heart disease and death from heart disease, and it represents an important health problem for the nation.
Women who develop high blood pressure in their 40s may be more likely to develop dementia years later, according to a study published in the October 4, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
To reduce the burden of anemia, health officials need a better picture of the disease's global impact, an understanding made viable by a portable and affordable way to analyze blood. Researchers at the University of Washington developed a device smaller than a toaster that can detect the level of hemoglobin in whole blood samples using optical absorbance. The work is published this week in AIP Advances.
Proactive monitoring of blood levels of the therapeutic drug infliximab was associated with improved outcomes including lower risk of surgery and hospitalization.
New insight into how the protein antithrombin works could lead to treatments not only for patients with antithrombin deficiency, but also to better-designed drugs for other blood disorders.
Shlomo Melmed, MB, ChB, executive vice president, Academic Affairs, and dean of the medical faculty at Cedars-Sinai, has won the 2018 Outstanding Scholarly Physician Award from the Endocrine Society, the largest global membership organization representing professionals in endocrinology. The annual award recognizes outstanding contributions to the practice of clinical endocrinology in academic settings.
Southern Illinois University School of Medicine and the University of Chicago Medicine will use a $1.13 million federal grant to study the opioid epidemic affecting the state’s 16 southernmost counties.
A review of the weight gain risks and challenges faced by women in midlife has led Mayo Clinic researchers to a series of recommendations for this patient population. The findings are published in this month's edition of Mayo Clinic Proceedings.
To pass the nearly 180 days she was a patient in Seattle Children’s Cancer Unit with graft-versus-host disease (GVHD), London Bowater took orders from her doctors, nurses and other patients and families for friendship bracelets that she would braid from her hospital bed.
Magnetic resonance imaging appears to be safe for patients with cardiac implantable electronic devices, even for chest imaging, according to a new study by researchers from the Intermountain Medical Center Heart Institute.
UNC School of Medicine cardiologist Anil Gehi, MD, will use a $1.7 million grant from the Bristol-Myers Squibb Foundation to further innovate a care model, launched in 2015, that reduced hospitalizations for patients with atrial fibrillation (Afib) presenting in the emergency room by more than 30 percentage points in its first year.
• Among hemodialysis patients admitted to the hospital, nearly a quarter of admissions were followed by an unplanned readmission within 30 days. • Most readmissions were for a diagnosis different than the one for the initial hospitalization. • A small proportion of patients accounted for a disproportionate number of readmissions.
A team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and Weill-Cornell Medical College have identified, for the first time, a new molecular pathway that is required for acute myeloid leukemia (AML) development. This work could provide a rationale for targeting the RNA methylation program in myeloid leukemia.
UVA has administered its first dose of an experimental gene therapy for a deadly form of treatment-resistant pediatric leukemia.
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment.
A new study finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer side effects, in patients undergoing joint replacement surgery.
A new study led by Washington University School of Medicine in St. Louis shows that dosing warfarin (Coumadin and others) is safer — producing fewer adverse events such as hemorrhage — when key elements of a patient’s genetic makeup are considered.
The University of Texas MD Anderson Cancer Center and Pfizer Inc. today announced that they have entered into a clinical collaboration to study novel combinations of three Pfizer investigational immuno-oncology therapies and other Pfizer agents in the treatment of various solid tumors and hematologic malignancies.
Two drugs, already approved for safe use in people, may be able to improve therapy for chronic myeloid leukemia (CML), a blood cancer that affects myeloid cells, according to results from a University of Iowa study in mice.
NCCN 12th Annual Congress: Hematologic Malignancies™ will be held October 6 – 7, 2017 in San Francisco, California, and features a new Nursing Forum.
Investigators at CHLA have identified the molecular pathway used to foster neuroblastoma and demonstrated use of a clinically available agent, ruxolitinib, to block the pathway.
Scientists have found that ignored pieces of DNA play a critical role in the development of immune cells (T cells). These areas activate a change in the structure of DNA that brings together crucial elements necessary for T cell formation. This “big bang” discovery may aid in combating diseases.
People with both high and low levels of magnesium in their blood may have a greater risk of developing dementia, according to a study published in the September 20, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Chicago (Sep. 20, 2017): The Association of Pediatric Hematology/Oncology Nurses (APHON) has awarded this year’s Dr. Patricia Greene Leadership Award to Amy Haskamp, MSN CNS RN CPON®. Haskamp was presented with this award at the 41st Annual APHON Conference and Exhibit, held August 17 -19, 2017 in Palm Springs, CA.
Chicago (Sep. 20, 2017): The Association of Pediatric Hematology/Oncology Nurses (APHON) has presented Jami Gattuso, MSN RN CPON® with the 2017 Dr. Casey Hooke Distinguished Service Award. Gattuso received her award at the 41st APHON Annual Conference and Exhibit, held August 17 – 19 in Palm Springs, CA. This award is presented to an APHON member who has demonstrated excellence to service and to leadership of APHON.
Chicago (Sep. 20, 2017): The Association of Pediatric Hematology/Oncology Nurses (APHON) has awarded Dianne Fochtman, PhD RN CPNP CHPPN CPON® with the 2017 Dr. Nancy E. Kline Mentoring Award. This award was presented to Fochtman at the 41st Annual APHON Conference and Exhibit, on August 18 in Palm Springs, CA.
Chicago (Sep. 20, 2017) The Association of Pediatric Hematology/Oncology Nurses (APHON) announced the recipients of the 2017 APHON Membership Awards at its 41st Annual Conference and Exhibit, held August 17-19 in Palm Springs, CA. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Chicago (Sept. 20, 2017): The Association of Pediatric Hematology/Oncology Nurses (APHON) elected Susan Burke, MA RN CPNP CPHON®, to serve as President for the 2017-2019 term. Burke officially took office at the recent 41st Annual APHON Conference and Exhibit, held August 17-19 in Palm Springs, CA.
Researchers at Joslin Diabetes Center have identified an unexpected natural protective factor against chronic inflammation that drives cardiovascular disease in type 2 diabetes.
A Ludwig Cancer Research study has uncovered a new mechanism by which cancer cells evade destruction by the immune system. The paper, led by Camilla Jandus of the Lausanne Branch of the Ludwig Institute for Cancer Research, describes how immune cells known as group 2 innate lymphoid cells (ILC2s) are recruited by leukemic cells to suppress an essential anticancer immune response.
Scientists have helped provide a way to better understand how to enable drugs to enter the brain and how cancer cells make it past the blood brain barrier.
Brandon Hudgins, professional long-distance runner, GPA/Wegener’s patient and leader of VF Team Brandon, has shared his story in his recently released book, “Going the Distance: The Journey of a Vasculitis Patient on the Road to Olympic Glory.”
There is an increased risk of thyroid cancer associated with lower-than-normal thyroid hormone levels, a finding that could have a major impact on patients fighting the disease.
Monroe Carell Jr. Children’s Hospital at Vanderbilt is part of a select group of health care institutions recently chosen to offer a new FDA-approved immunotherapy for a subset of pediatric acute lymphoblastic leukemia (ALL).
Leukemia survivor Jeffrey Hoffman owes his life to a complete stranger who altruistically donated bone marrow cells for Mr. Hoffman's successful bone marrow transplant. "It was a very noble thing to do," Mr. Hoffman said. On September 10, 2017, Mr. Hoffman (left) met his donor, Zachary Gold (right), for the first time, during Loyola Medicine's Bone Marrow TransplantCelebration of Survivorship. About 400 patients, family members, caregivers, donors, doctors and nurses attended the annual event at Loyola’s Cardinal Bernardin Cancer Center.
The University of Texas MD Anderson Cancer Center and Daiichi Sankyo Company, Limited today announced a multi-year collaboration focused on accelerating the development of novel therapies for acute myeloid leukemia (AML).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right